Ranked by reported Q2 2026 13F market value
Share of total reported institutional value in AGL held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | Rubicon Founders LLC | 105K | $11.3M | -58.1% | 0.631% | 5.75% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in AGL — a direct measure of their conviction.
Filings activity in AGL during Q2 2026, grouped by how each filer changed its position.
8 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q2 2026 | 1 | 75% | 0.63% | 1.67 pp | $11M | +257% |
| Q1 2026 | 4 | 98% | 2.30% | 87.22 pp | $3M | 99% |
| Q4 2025 | 193 | +3.8% | 89.52% | 3.18 pp | $254M | 35% |
| Q3 2025 | 186 | 8.4% | 92.70% | 3.65 pp | $393M | 57% |
| Q2 2025 | 203 | +5.7% | 96.35% | 1.27 pp | $912M | 47% |
| Q1 2025 | 192 | +4.3% | 97.62% | 2.99 pp | $1.73B | +122% |
| Q4 2024 | 184 | 11% | 100.61% | 3.59 pp | $783M | 53% |
| Q3 2024 | 206 | — | 104.20% | — | $1.68B | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
Institutional ownership and quarterly buying activity across the largest Healthcare Providers peers.
Quick answers to the most common questions about buying AGL stock.
Based on Q2 2026 13F filings, institutional ownership of Agilon Health, Inc. stands at 0.6%, held across 1 reporting institutions.
Rubicon Founders LLC is the largest reported institutional holder of AGL, with approximately 105,341 shares worth $0.01B as of Q2 2026.
No marquee "smart money" managers (Berkshire, Burry, ARK, Tiger Global, Pershing Square, Baupost, etc.) currently appear among the top 25 institutional holders of AGL.
Our composite Smart Money Score for AGL is 8 out of 100 (Heavy Distribution). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
0 institutions opened new positions in AGL during Q2 2026, while 3 fully exited. 1 added to existing positions and 0 trimmed.
AGL institutional ownership fell by 1.67 percentage points quarter-over-quarter, with a net change of -3 holders.
The top 10 institutions account for 100.0% of all reported 13F value in AGL, and the top 25 account for 100.0%.
Across the largest Healthcare Providers peers, institutional ownership levels are: STLN (43.0%), ACH (83.0%). See the peer comparison table on this page for net buyer activity by company.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.